| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.3 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.065 | 0.3 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.065 | 0.3 |